Drug Type Small molecule drug |
Synonyms Mometasone furoate/levocabastine hydrochloride, CKD-342 |
Target |
Action agonists, antagonists |
Mechanism GR agonists(Glucocorticoid receptor agonists), H1 receptor antagonists(Histamine H1 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC26H30ClFN2O2 |
InChIKeyOICFWWJHIMKBCD-VALQNVSPSA-N |
CAS Registry79547-78-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Rhinitis, Allergic, Perennial | Phase 3 | United States | 01 May 2015 |